Sanofi (NASDAQ:SNY) Issues Earnings Results

Sanofi (NASDAQ:SNY) released its quarterly earnings results on Thursday. The company reported $0.70 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.70, Zacks reports. Sanofi had a net margin of 9.96% and a return on equity of 27.45%.

Sanofi Stock Up 3.8 %

SNY stock opened at $54.15 on Friday. The stock has a market capitalization of $137.42 billion, a PE ratio of 27.63, a price-to-earnings-growth ratio of 1.21 and a beta of 0.57. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The firm has a 50 day moving average of $49.12 and a 200 day moving average of $52.24.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday. StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Sanofi presently has an average rating of “Moderate Buy” and a consensus target price of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.